| 000 | 01213 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517214615.0 | ||
| 264 | 0 | _c20190712 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1536-5166 | ||
| 024 | 7 |
_a10.1097/WNO.0000000000000659 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurton, Jodie M | |
| 245 | 0 | 0 |
_aThe Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis. _h[electronic resource] |
| 260 |
_bJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _c06 2018 |
||
| 300 |
_a210-216 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aFreedman, Mark S | |
| 773 | 0 |
_tJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _gvol. 38 _gno. 2 _gp. 210-216 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNO.0000000000000659 _zAvailable from publisher's website |
| 999 |
_c28380975 _d28380975 |
||